Chagas disease affects about 25 million people in the world and is caused by Trypanosoma cruzi (T.c.). Currently, the only two drugs available for the its treatment - Benzonidazol (BZ) and nifurtimox - cause adverse effects in the patient. With this, new drugs have been studied in order to find more efficient therapeutic strategies, such as N, N'-Squaramide 17 (S), which represents a compound with excellent therapeutic potential. By means of nanotechnology, it is possible to improve the drug act

Detalhes bibliográficos
Data de Publicação: 2018
Tipo de documento: Dissertação
Título da fonte: Portal de Dados Abertos da CAPES
Texto Completo: https://sucupira.capes.gov.br/sucupira/public/consultas/coleta/trabalhoConclusao/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=6546321
id BRCRIS_de2c598b4e170ec2c68a20f2dfc37caa
network_acronym_str CAPES
network_name_str Portal de Dados Abertos da CAPES
dc.title.pt-BR.fl_str_mv Chagas disease affects about 25 million people in the world and is caused by Trypanosoma cruzi (T.c.). Currently, the only two drugs available for the its treatment - Benzonidazol (BZ) and nifurtimox - cause adverse effects in the patient. With this, new drugs have been studied in order to find more efficient therapeutic strategies, such as N, N'-Squaramide 17 (S), which represents a compound with excellent therapeutic potential. By means of nanotechnology, it is possible to improve the drug act
title Chagas disease affects about 25 million people in the world and is caused by Trypanosoma cruzi (T.c.). Currently, the only two drugs available for the its treatment - Benzonidazol (BZ) and nifurtimox - cause adverse effects in the patient. With this, new drugs have been studied in order to find more efficient therapeutic strategies, such as N, N'-Squaramide 17 (S), which represents a compound with excellent therapeutic potential. By means of nanotechnology, it is possible to improve the drug act
spellingShingle Chagas disease affects about 25 million people in the world and is caused by Trypanosoma cruzi (T.c.). Currently, the only two drugs available for the its treatment - Benzonidazol (BZ) and nifurtimox - cause adverse effects in the patient. With this, new drugs have been studied in order to find more efficient therapeutic strategies, such as N, N'-Squaramide 17 (S), which represents a compound with excellent therapeutic potential. By means of nanotechnology, it is possible to improve the drug act
Nanociência. Nanotecnologia. Nanotoxicologia. Citotoxicidade. Genotoxicidade. Nanopartículas de ferrita de manganês. MnFe2O4. BEAS-2B.
title_short Chagas disease affects about 25 million people in the world and is caused by Trypanosoma cruzi (T.c.). Currently, the only two drugs available for the its treatment - Benzonidazol (BZ) and nifurtimox - cause adverse effects in the patient. With this, new drugs have been studied in order to find more efficient therapeutic strategies, such as N, N'-Squaramide 17 (S), which represents a compound with excellent therapeutic potential. By means of nanotechnology, it is possible to improve the drug act
title_full Chagas disease affects about 25 million people in the world and is caused by Trypanosoma cruzi (T.c.). Currently, the only two drugs available for the its treatment - Benzonidazol (BZ) and nifurtimox - cause adverse effects in the patient. With this, new drugs have been studied in order to find more efficient therapeutic strategies, such as N, N'-Squaramide 17 (S), which represents a compound with excellent therapeutic potential. By means of nanotechnology, it is possible to improve the drug act
title_fullStr Chagas disease affects about 25 million people in the world and is caused by Trypanosoma cruzi (T.c.). Currently, the only two drugs available for the its treatment - Benzonidazol (BZ) and nifurtimox - cause adverse effects in the patient. With this, new drugs have been studied in order to find more efficient therapeutic strategies, such as N, N'-Squaramide 17 (S), which represents a compound with excellent therapeutic potential. By means of nanotechnology, it is possible to improve the drug act
Chagas disease affects about 25 million people in the world and is caused by Trypanosoma cruzi (T.c.). Currently, the only two drugs available for the its treatment - Benzonidazol (BZ) and nifurtimox - cause adverse effects in the patient. With this, new drugs have been studied in order to find more efficient therapeutic strategies, such as N, N'-Squaramide 17 (S), which represents a compound with excellent therapeutic potential. By means of nanotechnology, it is possible to improve the drug act
title_full_unstemmed Chagas disease affects about 25 million people in the world and is caused by Trypanosoma cruzi (T.c.). Currently, the only two drugs available for the its treatment - Benzonidazol (BZ) and nifurtimox - cause adverse effects in the patient. With this, new drugs have been studied in order to find more efficient therapeutic strategies, such as N, N'-Squaramide 17 (S), which represents a compound with excellent therapeutic potential. By means of nanotechnology, it is possible to improve the drug act
Chagas disease affects about 25 million people in the world and is caused by Trypanosoma cruzi (T.c.). Currently, the only two drugs available for the its treatment - Benzonidazol (BZ) and nifurtimox - cause adverse effects in the patient. With this, new drugs have been studied in order to find more efficient therapeutic strategies, such as N, N'-Squaramide 17 (S), which represents a compound with excellent therapeutic potential. By means of nanotechnology, it is possible to improve the drug act
title_sort Chagas disease affects about 25 million people in the world and is caused by Trypanosoma cruzi (T.c.). Currently, the only two drugs available for the its treatment - Benzonidazol (BZ) and nifurtimox - cause adverse effects in the patient. With this, new drugs have been studied in order to find more efficient therapeutic strategies, such as N, N'-Squaramide 17 (S), which represents a compound with excellent therapeutic potential. By means of nanotechnology, it is possible to improve the drug act
topic Nanociência. Nanotecnologia. Nanotoxicologia. Citotoxicidade. Genotoxicidade. Nanopartículas de ferrita de manganês. MnFe2O4. BEAS-2B.
publishDate 2018
format masterThesis
url https://sucupira.capes.gov.br/sucupira/public/consultas/coleta/trabalhoConclusao/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=6546321
author_role author
dc.contributor.advisor1.fl_str_mv Graziella Anselmo Joanitti
dc.contributor.advisor1Lattes.fl_str_mv http://lattes.cnpq.br/1434775469286578
dc.contributor.advisor1orcid.por.fl_str_mv https://orcid.org/0000000268881284
dc.publisher.none.fl_str_mv UNIVERSIDADE DE BRASÍLIA
publisher.none.fl_str_mv UNIVERSIDADE DE BRASÍLIA
instname_str UNIVERSIDADE DE BRASÍLIA
dc.publisher.program.fl_str_mv Nanociência e Nanobiotecnologia
dc.description.course.none.fl_txt_mv Nanociência e Nanobiotecnologia
reponame_str Portal de Dados Abertos da CAPES
collection Portal de Dados Abertos da CAPES
spelling CAPESPortal de Dados Abertos da CAPESChagas disease affects about 25 million people in the world and is caused by Trypanosoma cruzi (T.c.). Currently, the only two drugs available for the its treatment - Benzonidazol (BZ) and nifurtimox - cause adverse effects in the patient. With this, new drugs have been studied in order to find more efficient therapeutic strategies, such as N, N'-Squaramide 17 (S), which represents a compound with excellent therapeutic potential. By means of nanotechnology, it is possible to improve the drug actChagas disease affects about 25 million people in the world and is caused by Trypanosoma cruzi (T.c.). Currently, the only two drugs available for the its treatment - Benzonidazol (BZ) and nifurtimox - cause adverse effects in the patient. With this, new drugs have been studied in order to find more efficient therapeutic strategies, such as N, N'-Squaramide 17 (S), which represents a compound with excellent therapeutic potential. By means of nanotechnology, it is possible to improve the drug actChagas disease affects about 25 million people in the world and is caused by Trypanosoma cruzi (T.c.). Currently, the only two drugs available for the its treatment - Benzonidazol (BZ) and nifurtimox - cause adverse effects in the patient. With this, new drugs have been studied in order to find more efficient therapeutic strategies, such as N, N'-Squaramide 17 (S), which represents a compound with excellent therapeutic potential. By means of nanotechnology, it is possible to improve the drug actChagas disease affects about 25 million people in the world and is caused by Trypanosoma cruzi (T.c.). Currently, the only two drugs available for the its treatment - Benzonidazol (BZ) and nifurtimox - cause adverse effects in the patient. With this, new drugs have been studied in order to find more efficient therapeutic strategies, such as N, N'-Squaramide 17 (S), which represents a compound with excellent therapeutic potential. By means of nanotechnology, it is possible to improve the drug actChagas disease affects about 25 million people in the world and is caused by Trypanosoma cruzi (T.c.). Currently, the only two drugs available for the its treatment - Benzonidazol (BZ) and nifurtimox - cause adverse effects in the patient. With this, new drugs have been studied in order to find more efficient therapeutic strategies, such as N, N'-Squaramide 17 (S), which represents a compound with excellent therapeutic potential. By means of nanotechnology, it is possible to improve the drug actChagas disease affects about 25 million people in the world and is caused by Trypanosoma cruzi (T.c.). Currently, the only two drugs available for the its treatment - Benzonidazol (BZ) and nifurtimox - cause adverse effects in the patient. With this, new drugs have been studied in order to find more efficient therapeutic strategies, such as N, N'-Squaramide 17 (S), which represents a compound with excellent therapeutic potential. By means of nanotechnology, it is possible to improve the drug actChagas disease affects about 25 million people in the world and is caused by Trypanosoma cruzi (T.c.). Currently, the only two drugs available for the its treatment - Benzonidazol (BZ) and nifurtimox - cause adverse effects in the patient. With this, new drugs have been studied in order to find more efficient therapeutic strategies, such as N, N'-Squaramide 17 (S), which represents a compound with excellent therapeutic potential. By means of nanotechnology, it is possible to improve the drug actNanociência. Nanotecnologia. Nanotoxicologia. Citotoxicidade. Genotoxicidade. Nanopartículas de ferrita de manganês. MnFe2O4. BEAS-2B.2018masterThesishttps://sucupira.capes.gov.br/sucupira/public/consultas/coleta/trabalhoConclusao/viewTrabalhoConclusao.jsf?popup=true&id_trabalho=6546321authorGraziella Anselmo Joanittihttp://lattes.cnpq.br/1434775469286578https://orcid.org/0000000268881284UNIVERSIDADE DE BRASÍLIAUNIVERSIDADE DE BRASÍLIAUNIVERSIDADE DE BRASÍLIANanociência e NanobiotecnologiaNanociência e NanobiotecnologiaPortal de Dados Abertos da CAPESPortal de Dados Abertos da CAPES
_version_ 1741890418220466176

Registros relacionados